NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hangzhou Yuannang Biotechnology Co., Ltd.

Hangzhou Yuannang Biotechnology Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://www.premiumtimesng.com/

Last Round

Series A

Sep 11, 2025

Total Funding Raised

$14M

Company Overview

Hangzhou Yuannang Biotechnology Co., Ltd. is a biotechnology company that develops biodegradable bone adhesives for orthopedic trauma repair.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

bone adhesivebiomaterialsorthopedic implantsbiodegradable materialsbone gluemedical devicefracture repairregenerative medicinebiomimetic adhesiveorthopedic surgeryNMPA approvalclinical trialssurgical hardwarebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hangzhou Yuannang Biotechnology Co., Ltd. Comparables

Compare Hangzhou Yuannang Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Hangzhou Yuannang Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RevBio, Inc.
85%
Biomimetic Innovations
80%
Sanara Medtech Inc
70%

Hangzhou Yuannang Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 11, 2025
Early FundingAug 1, 2022
AngelOct 1, 2021

Key People

Founding team and executive leadership

Musikilu Mojeed

Editor-in-Chief Chief Operating Officer

Executive Team

Hangzhou Yuannang Biotechnology Co., Ltd. Investors

Notable investors and investment history

Hangzhou Yuannang Biotechnology Co., Ltd. investors
InvestorRounds
Zheshang Venture CapitalAngel, Series A, Early Funding

Hangzhou Yuannang Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hangzhou Yuannang Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hangzhou Yuannang Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range99
Year FoundedN/A
Last FundingSep 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.